Bicalutamide CAS 90357-06-5 API Factory Provectus Prostatae Cancer

Description:

Nomen: Bicalutamide

CAS: 90357-06-5

Aspectus: Alba ad Off-White Crystalline pulveris

Intenta: 98.0%~ 102.0%

Bicalutamide in curatione Cancri Prostatae Provectae

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen: Bicalutamide
CAS: 90357-06-5
Bicalutamide in curatione Cancri Prostatae Provectae
API High Quality, Commercial Production

Chemical Properties:

Nomen	Bicalutamide
Synonyma	N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide
CAS Number	90357-06-5
CATTUS Number	RF-API76
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C18H14F4N2O4S
M. Pondus	430.37
Repono Temperature	2-8℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White Crystalline pulveris
Lepidium sativum	IR: Imaginis specimen correspondet relationis vexillum
Lepidium sativum B *	HPLC: Retentionis tempus solutionis maioris cacuminis sample solutionis respondet solutionis vexillum
Lepidium sativum C*	Organicum Fluoride Lepidium sativum
Solubilitas	Gratis solutum in Acetone et Tetrahydrofuran, Paulo solutum in Ethyl Acetate.
Liquescens punctum	191.0~ 195.0℃
Aqua Content (per KF)	≤0.20%
Fluoride Content	15.9%~ 18.5%
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.10%
Metalla gravis	≤10ppm
RELICTUM Solvents
Tetrahydrofuran	≤0.072%
Toluene	≤0.089%
N-Hexane	≤0.029%
Acetone	≤0.50%
Ethyl Acetate	≤0.50%
Substantiae cognatae
N,N'-Dimethyl Acetamide	≤0.109%
Bicalutamide Aminobenzonitrile	≤0.10%
Bicalutamide Related Compone A Isomer A	≤0.10%
Bicalutamide Related Compone A Isomer B	≤0.10%
Desfluoro Bicalutamide	≤0.20%
2-Fluoro Bicalutamide	≤0.20%
Deoxy Bicalutamide	≤0.20%
Bicalutamide Sulfide	≤0.10%
Quis non specificatus immunditia	≤0.10%
Totalis immunditias	≤0.50%
Magnitudo particula	90%<10um;L%<5um
Assay	98.0% ~ 102.0% (ex exaruit basis)
Microbiological Test
Summa Viable Aerobic Comitis	≤500CFU/g*
Fermenta et Molds	≤50CFU/g*
Fasciae vita	XXIV Menses
Test Standard	Enterprise Latin;USP Standard
Consuetudinem	API, in curatione Cancri Prostatae Provectae

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Bicalutamide (CAS: 90357-06-5) est antagonista non steroidalis androgeni, quae cum androgenio receptori cum androgen certat, impedimentum cellularum androgenium impedit, et ligamen androgenis ad organum scopo vetat.Cum androgen receptori obligat formas receptantis complexi, quae nucleum intrat et cum nucleoprotein componitur, consequenter incrementum cellae tumoris inhibens.Potest esse sicut medicamentum primae lineae pro palliativa curatione cancri prostatae provectae.Bicalutamide in Britanniae Regnum, primum eius mercatum universale, deductum est ad tractationem cancri prostatae in compositione cum castratione LHRH analogi vel chirurgici.Non-steroidale, peripheraliter antiandrogenium selectivum, bicalutamide vetat actionem dihydrotestosteronis et testosteronis in locis scopo, vinculo competitive ad cytosolic androgeni receptoris.Bene toleratum est parem non esse significantes cardiovasculares et metabolicos effectus propter commodum cuiuslibet actionis steroidei carere.Efficacia bicalutamidis sicut monotherapia amet demonstrata est.Rates responsionis pollicentes nuntiaverunt etiam in tractando carcinomata colorectales, pectus, pancreas et non parvas cellula pulmonis.